Page last updated: 2024-11-04

sulfaphenazole and Hyperparathyroidism, Primary

sulfaphenazole has been researched along with Hyperparathyroidism, Primary in 1 studies

Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Virdis, A1
Cetani, F1
Giannarelli, C1
Banti, C1
Ghiadoni, L1
Ambrogini, E1
Carrara, D1
Pinchera, A1
Taddei, S1
Bernini, G1
Marcocci, C1

Other Studies

1 other study available for sulfaphenazole and Hyperparathyroidism, Primary

ArticleYear
The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:2

    Topics: Adult; Aged; Aryl Hydrocarbon Hydroxylases; Ascorbic Acid; Biological Factors; Cytochrome P-450 CYP2

2010